Entries by admin

ROS1 rearrangements occur in approximately 1% of patients with NSCLC

The Promising Therapeutic Strategy against ALKoma and ROS1-positive Tumors It has recently been identified that crizotinib significantly inhibits the tumor cells with ALK-fusion genes or ROS1-rearranged driver genes which encode constitutive tyrosine kinase receptors. The emerging concept of lung cancer stem cells (CSCs) arises a question of the relationship between CSCs and ROS1 gene rearrangement. […]

Welcome to Sapien Biosciences

We are under construction Please check back later for more updates

Apollo Hospitals & Saarum Innovations launch Sapien Biosciences

Welcome to Sapienbio Blog This article originally appeared in 2013 Joint Venture to create a world-class human bio-bank and personalized medicine company, first of its kind in India to enableinnovative research & clinical applications Hyderabad, September 23, 2013: Apollo Hospitals with Saarum Innovations, launched its joint venture ‘Sapien Biosciences’ today at Hyderabad to create aworld-class […]

Apollo Hospitals set to integrate clinical genomics as part of its personalized medicine initiatives

Note: This article originally appeared in September, 2013 Sapien Biosciences, an Apollo subsidiary, to spearhead the introduction of cutting-edge genomic testing across the Apollo network Apollo Hospitals today announced the introduction of several genomic tests as part of its personalized medicine initiative. The introduction of these tests, over the next few months, shall be spearheaded […]

Sapien Biosciences Inaugural Launch Videos

Apollo Hospitals & Saarum Innovations Launch Sapien Biosciences Dr. Jugnu Jain Sapien Biosciences Co-Founder & Chief Scientific Officer Sreevastsa Natarajan Sapien Biosciences Co-Founder & Chief Scientific Officer Shobana Kamineni Apollo Hospitals Enterprise New Initiatives Executive Director Dr. Hariprasad Apollo Hospitals Enterprise Central Region CEO